These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26299294)

  • 1. Meta-Analysis: Risk of Tics Associated With Psychostimulant Use in Randomized, Placebo-Controlled Trials.
    Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Coughlin CG; Leckman JF; Bloch MH
    J Am Acad Child Adolesc Psychiatry; 2015 Sep; 54(9):728-36. PubMed ID: 26299294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.
    Coughlin CG; Cohen SC; Mulqueen JM; Ferracioli-Oda E; Stuckelman ZD; Bloch MH
    J Child Adolesc Psychopharmacol; 2015 Oct; 25(8):611-7. PubMed ID: 26402485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis.
    Stuckelman ZD; Mulqueen JM; Ferracioli-Oda E; Cohen SC; Coughlin CG; Leckman JF; Bloch MH
    J Clin Psychiatry; 2017 Jun; 78(6):e648-e655. PubMed ID: 28682529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological treatment for Attention Deficit Hyperactivity Disorder (ADHD) in children with comorbid tic disorders.
    Pringsheim T; Steeves T
    Cochrane Database Syst Rev; 2011 Apr; (4):CD007990. PubMed ID: 21491404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
    Osland ST; Steeves TD; Pringsheim T
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD007990. PubMed ID: 29944175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
    Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
    Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
    Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
    Erenberg G
    Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of extended-release guanfacine and psychostimulants for attention-deficit/hyperactivity disorder.
    Wilens TE; Bukstein O; Brams M; Cutler AJ; Childress A; Rugino T; Lyne A; Grannis K; Youcha S
    J Am Acad Child Adolesc Psychiatry; 2012 Jan; 51(1):74-85.e2. PubMed ID: 22176941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergence of tics in children with ADHD: impact of once-daily OROS methylphenidate therapy.
    Palumbo D; Spencer T; Lynch J; Co-Chien H; Faraone SV
    J Child Adolesc Psychopharmacol; 2004; 14(2):185-94. PubMed ID: 15319016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral vasculopathy associated with psychostimulant treatment in children with attention-deficit/hyperactivity disorder.
    Yu ZJ; Parker-Kotler C; Tran K; Weller RA; Weller EB
    Curr Psychiatry Rep; 2010 Apr; 12(2):111-5. PubMed ID: 20425295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
    Varley CK; Vincent J; Varley P; Calderon R
    Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanfacine extended release as adjunctive therapy to psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Childress AC
    Adv Ther; 2012 May; 29(5):385-400. PubMed ID: 22610723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ.
    Aman MG; Binder C; Turgay A
    J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response/remission with guanfacine extended-release and psychostimulants in children and adolescents with attention-deficit/hyperactivity disorder.
    Cutler AJ; Brams M; Bukstein O; Mattingly G; McBurnett K; White C; Rubin J
    J Am Acad Child Adolesc Psychiatry; 2014 Oct; 53(10):1092-101. PubMed ID: 25245353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
    Roessner V; Robatzek M; Knapp G; Banaschewski T; Rothenberger A
    Dev Med Child Neurol; 2006 Jul; 48(7):616-21. PubMed ID: 16780635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
    Schachter HM; Pham B; King J; Langford S; Moher D
    CMAJ; 2001 Nov; 165(11):1475-88. PubMed ID: 11762571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
    Law SF; Schachar RJ
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):944-51. PubMed ID: 10434485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rebound effects with long-acting amphetamine or methylphenidate stimulant medication preparations among adolescent male drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Moore M; Burket R; Merkel RL; Mikami AY; Kovatchev B
    J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):1-10. PubMed ID: 18294083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of psychostimulant drugs for amphetamine abuse or dependence.
    Pérez-Mañá C; Castells X; Torrens M; Capellà D; Farre M
    Cochrane Database Syst Rev; 2013 Sep; (9):CD009695. PubMed ID: 23996457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.